William Blair Investment Management LLC Acquires 731,169 Shares of Quanterix Corporation $QTRX

William Blair Investment Management LLC boosted its holdings in shares of Quanterix Corporation (NASDAQ:QTRX) by 55.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 2,046,449 shares of the company’s stock after buying an additional 731,169 shares during the quarter. William Blair Investment Management LLC’s holdings in Quanterix were worth $13,015,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Farther Finance Advisors LLC acquired a new position in shares of Quanterix in the 4th quarter valued at $26,000. Quarry LP boosted its position in shares of Quanterix by 277,300.0% in the 3rd quarter. Quarry LP now owns 5,548 shares of the company’s stock worth $30,000 after purchasing an additional 5,546 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Quanterix during the third quarter worth $64,000. HUB Investment Partners LLC bought a new stake in Quanterix in the second quarter valued at about $81,000. Finally, Jain Global LLC bought a new stake in Quanterix in the third quarter valued at about $94,000. Institutional investors own 86.48% of the company’s stock.

Quanterix Stock Performance

Shares of Quanterix stock opened at $2.69 on Tuesday. The company has a market capitalization of $126.73 million, a PE ratio of -1.14 and a beta of 1.15. Quanterix Corporation has a 12 month low of $2.39 and a 12 month high of $8.77. The stock’s fifty day simple moving average is $3.40 and its 200 day simple moving average is $5.36.

Quanterix (NASDAQ:QTRX) last posted its earnings results on Wednesday, May 6th. The company reported ($0.39) earnings per share for the quarter, topping the consensus estimate of ($0.51) by $0.12. Quanterix had a negative return on equity of 23.92% and a negative net margin of 71.86%.The firm had revenue of $35.90 million for the quarter, compared to analyst estimates of $36.84 million. Analysts predict that Quanterix Corporation will post -0.97 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

QTRX has been the topic of a number of recent analyst reports. TD Cowen reduced their target price on Quanterix from $7.00 to $4.00 and set a “hold” rating on the stock in a report on Thursday, May 7th. Wall Street Zen raised Quanterix from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings downgraded shares of Quanterix from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Finally, Canaccord Genuity Group reduced their price objective on shares of Quanterix from $8.00 to $4.00 and set a “hold” rating on the stock in a research note on Monday, April 20th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average target price of $4.00.

Quanterix Profile

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.